A new approach to the therapy of cancer based on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2

S. A. Rosenberg, M. T. Lotze, L. M. Muul, S. Leitman, A. E. Chang, J. T. Vetto, C. A. Seipp, C. Simpson

Research output: Contribution to journal › Article › peer-review

86 Scopus citations

Fingerprint

Dive into the research topics of 'A new approach to the therapy of cancer based on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2'. Together they form a unique fingerprint.

Medicine & Life Sciences